Pharmacogenomics spotlight commentary: From the United Kingdom to global populations
Research output: Contribution to journal › Comment/debate › peer-review
Standard Standard
Pharmacogenomics spotlight commentary: From the United Kingdom to global populations. / Magavern, Emma F.; Daly, Ann K.; Gilchrist, Annette et al.
In: British Journal of Clinical Pharmacology, Vol. 87, No. 12, 14917, 12.2021, p. 4546-4548.
In: British Journal of Clinical Pharmacology, Vol. 87, No. 12, 14917, 12.2021, p. 4546-4548.
Research output: Contribution to journal › Comment/debate › peer-review
HarvardHarvard
Magavern, EF, Daly, AK, Gilchrist, A & Hughes, D 2021, 'Pharmacogenomics spotlight commentary: From the United Kingdom to global populations', British Journal of Clinical Pharmacology, vol. 87, no. 12, 14917, pp. 4546-4548. https://doi.org/10.1111/bcp.14917
APA
Magavern, E. F., Daly, A. K., Gilchrist, A., & Hughes, D. (2021). Pharmacogenomics spotlight commentary: From the United Kingdom to global populations. British Journal of Clinical Pharmacology, 87(12), 4546-4548. Article 14917. https://doi.org/10.1111/bcp.14917
CBE
Magavern EF, Daly AK, Gilchrist A, Hughes D. 2021. Pharmacogenomics spotlight commentary: From the United Kingdom to global populations. British Journal of Clinical Pharmacology. 87(12):4546-4548. https://doi.org/10.1111/bcp.14917
MLA
Magavern, Emma F. et al. "Pharmacogenomics spotlight commentary: From the United Kingdom to global populations". British Journal of Clinical Pharmacology. 2021, 87(12). 4546-4548. https://doi.org/10.1111/bcp.14917
VancouverVancouver
Magavern EF, Daly AK, Gilchrist A, Hughes D. Pharmacogenomics spotlight commentary: From the United Kingdom to global populations. British Journal of Clinical Pharmacology. 2021 Dec;87(12):4546-4548. 14917. Epub 2021 May 25. doi: https://doi.org/10.1111/bcp.14917
Author
RIS
TY - JOUR
T1 - Pharmacogenomics spotlight commentary: From the United Kingdom to global populations
AU - Magavern, Emma F.
AU - Daly, Ann K.
AU - Gilchrist, Annette
AU - Hughes, Dyfrig
PY - 2021/12
Y1 - 2021/12
U2 - https://doi.org/10.1111/bcp.14917
DO - https://doi.org/10.1111/bcp.14917
M3 - Comment/debate
VL - 87
SP - 4546
EP - 4548
JO - British Journal of Clinical Pharmacology
JF - British Journal of Clinical Pharmacology
SN - 0306-5251
IS - 12
M1 - 14917
ER -